Wuxi Apptec (Hongkong) LIMITED

UEI
JKRKL5UBGYY5
CAGE
SAQJ8
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Limited Liability Company
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Website
wuxiapptec.com
Founded
2000
Employees
10K-50K
Estimated annual revenue
$1B-$10B
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 -$9,750
FY2025 -$737
FY2024 -$51,800
FY2023 -$7,800

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Wuxi Apptec (Hongkong) LIMITED is a global company that provides a broad portfolio of R&D and manufacturing services to the pharmaceutical and healthcare industry, including chemistry drug CRDMO, biology discovery, preclinical testing, clinical research services, cell therapy, and gene therapy. Through prime federal contract awards, Wuxi Apptec (Hongkong) LIMITED has provided chemical compounds, small molecule compound libraries, analogues, and other materials to the National Institutes of Health (NIH), including the National Center for Advancing Translational Sciences (NCATS), National Cancer Institute (NCI), National Institute on Drug Abuse, National Heart Lung and Blood Institute, and National Institute of Allergy and Infectious Diseases. The contract awards have been for purposes such as testing anti-cancer drug candidates, lowering triglycerides, DNA conjugation chemistry, and scaling up lead compounds. None of the prime contract awards have had any set aside designations. Wuxi Apptec (Hongkong) LIMITED has also received one sub contract award from Selux Diagnostics to provide critical material for a G2 Inoculator.

Quick answers

Is Wuxi Apptec (Hongkong) LIMITED registered in SAM.gov?

Wuxi Apptec (Hongkong) LIMITED's SAM.gov registration expired on November 12, 2022.

What is Wuxi Apptec (Hongkong) LIMITED's CAGE code?

Wuxi Apptec (Hongkong) LIMITED's CAGE code is SAQJ8, and its Unique Entity ID (UEI) is JKRKL5UBGYY5.

What is Wuxi Apptec (Hongkong) LIMITED's most recent federal award?

Wuxi Apptec (Hongkong) LIMITED's most recent federal contract award is NIH nhlbi lab researcher DR. Denis sviridov requires synthesis of triglycerides lowering peptides in order to… (75N92022P00066), from National Heart Lung and Blood Institute (NIH), on January 18, 2022.

On GovTribe

See Wuxi Apptec (Hongkong) LIMITED's full federal record

  • Federal contract awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe